Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Clinical trial NCT02343718 · COMPLETED
Trial details
- NCT number
- NCT02343718
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-24
- Primary completion
- 2017-09-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.